Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phenotype-Guided Renal Denervation: the Key to Therapeutic Response.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026

Same author

Optimization and Real-World Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: A Contemporary Clinical Review.

Cardiology research·2026

Same author

Transcription enhanced associate domain factor 1 (TEAD1) predicts liver regeneration outcome of ALPPS-treated patients.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2025

Same author

A pair of two atrial myxomas mimic thrombus in left atrial appendage and cause ischemic stroke in a young adult: a case report.

European heart journal. Case reports·2024

Same author

Suprarenal interrupted inferior cava with azygos continuation in a patient with pulmonary embolism: a case report.

European heart journal. Case reports·2024

Same author

Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany Study.

Journal of clinical medicine·2021

Same journal

Integrated Network Pharmacology and Experimental Validation Approach to Systematically Elucidate the Cardioprotective Mechanisms of Shengmai Injection.

Cardiovascular therapeutics·2026

Same journal

Prasugrel: Reassessing Its Role in Contemporary Antiplatelet Therapy.

Cardiovascular therapeutics·2026

Same journal

Correction to "Association of Initial Laxative Strategy With Clinical Outcomes in Critically Ill Patients With Acute Myocardial Infarction: A Retrospective Cohort Study".

Cardiovascular therapeutics·2026

Same journal

Baseline Ejection Fraction as a Modifier of Beta-Blocker Therapeutic Effects in Post-Acute Coronary Syndrome Patients With Non-Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.

Cardiovascular therapeutics·2026

Same journal

The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In-Stent Restenosis.

Cardiovascular therapeutics·2026

Same journal

Lycorine Attenuates Cardiac Fibrosis Through the Regulation of PYK2 Expression and Activity.

Cardiovascular therapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Stem cell therapy in cardiovascular disorders.

Korff Krause¹, Carsten Schneider, Karl-Heinz Kuck

¹Hanseatic Heart Center Hamburg, Department of Cardiology, Asklepios Hospital St. Georg, Hamburg, Germany. k.krause@asklepios.com

Cardiovascular Therapeutics

|November 6, 2010

Summary

This summary is machine-generated.

Stem cell therapy shows promise for heart repair, but clinical trial results for cardiac regeneration are controversial due to inconsistent methods. Further research is needed for effective myocardial stem cell therapy.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: Jun 7, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

Cardiovascular Research
Regenerative Medicine
Stem Cell Biology

Background:

Heart failure remains a leading cause of mortality despite current treatments.
Stem cell research offers potential for cardiac repair, but clinical translation faces challenges.

Purpose of the Study:

To review the potential and clinical translation of cell-based therapies for cardiovascular disease.
To discuss the challenges and ongoing debates in myocardial stem cell therapy.

Main Methods:

Review of laboratory research and clinical trials on stem and progenitor cells for cardiac repair.
Analysis of different cell-based repair mechanisms: replacement, restoration, and regeneration.

Main Results:

Clinical trials using mostly bone marrow-derived cells for ischemic heart disease have yielded controversial effectiveness results.
Lack of standardization in cell isolation and delivery methods contributes to inconsistent trial outcomes.
Significant therapeutic regeneration of human myocardium has not yet been definitively proven.

Conclusions:

The clinical translation of stem cell therapy for heart disease requires addressing critical issues like cell type, dosage, timing, and delivery.
Further standardization and research are essential to realize the therapeutic potential of cell-based cardiac repair.